Qingzhi Gao——Professor | 
                        |
| 
                             Nationality: 
                           | 
                          
                            
                             CHINA 
                           | 
                        
| 
                             Phone: 
                           | 
                          
                             022-27892050 
                           | 
                        
| 
                             Email: 
                           | 
                          
                             qingzhi@tju.edu.cn 
                           | 
                        
| 
                             Office: 
                           | 
                          
                             Room A609, Building 24, Tianjin University 
                           | 
                        
| 
                             School: 
                           | 
                          
                             School of Pharmaceutical Science and Technology 
                           | 
                        
| 
                             ResearcherID: 
                           | 
                          |
| 1994 | Ph. D. | Nagoya University, JP | 
| 1994-1999 | Postdoctoral | Stanford University, USA | 
| 1994-2001 | Research Scientist | Tokyo, JAPAN | 
| 1999-2000 | Postdoctoral fellow | Stanford University, California, USA | 
| 2001-2009 | Senior Research Scientist | XenoPort, Inc. California, USA | 
| 2009-2015 | Professor | Tianjin University, Tianjin, CHINA | 
| 2010-2015 | Director | Tianjin Key Laboratory | 
| Qian Mi, Yuru Ma, Ran Liu, Xiangqian Gao, Pengxing Liu, Yi Mi, Xuegang Fu, and QingzhiGao*, 2-Deoxyglucose Conjugated Platinum (II) Complexes for Targeted Therapy: Design, Synthesis, and Antitumor Activity. Journal of Biomolecular Structure & Dynamics, 2015, 30,1-12. | 
| Hong Li, Xiangqian Gao, Ran Liu, Yu Wang, Menghua Zhang, Zheng Fu, Yi Mi, Yiqiang Wang, Zhi Yao, Qingzhi Gao*, Glucose conjugated platinum(II) complex: Antitumor superiority to oxaliplatin, combination effect and mechanism of action. European Journal of Medicinal Chemistry, 2015, 101, 400-408. | 
| Liu, P.; Lu, Y.; Li, H.; Gao, X.; Liu, R.; Zhang-Negrerie, D.; Shi, Y.; Wang, Y.; Wang, S.; Gao, Q. Highly Water-soluble Platinum(II) Complex as GLUT Substrate for Targeted Therapy: Improved Anticancer Efficacy and Ttransporter-mediated Cytotoxic Properties. Chem. Commun. 2013, 49, 2421. | 
| Lu, Y.; Gao, X.; Wu, M.; Zhang-Negrerie, D.; Gao, Q. Strategies on the Development of Small Molecule Anticancer Drugs for Targeted Therapy. Mini-Rev in Med. Chem. 2011, 11, 611. | 
| Qingzhi Gao, Q.; Yang, L.; Zhu, Y. Pharmacophore Based Drug Design Approach as a Practical Process in Drug Discovery Current. Comput-Aided Drug Design 2010, 6, 37. | 
| Ye, Y.; Wei, J.; Dai, X.; Gao, Q. Computational Studies of the Binding Modes of A2A Adenosine Receptor Antagonists. Amino Acids 2008, 35, 389. | 
| Wei, J.; Wang, S.; Gao, S.; Dai X.; Qingzhi Gao, Q. 3D-Pharmacophore Models for Selective A2A and A2B Adenosine Receptor Antagonists. J. Chem. Inf. Model 2007, 47, 613. | 
| Year | Title | Author(s) | Source | Volume | 
|---|---|---|---|---|
| 2007 | 3D-pharmacophore models for selective A(2A) and A(2B) adenosine receptor antagonists | Wei, Jing; Wang, Songqing; Gao, Shaofen; et al. | Journal of Chemical Information and Modeling | 47 |